<DOC>
	<DOCNO>NCT00765128</DOCNO>
	<brief_summary>The purpose study determine whether continuous intravenous ketorolac infusion reduces pain patient percutaneous nephrolithotomy kidney stone disease .</brief_summary>
	<brief_title>Intravenous Ketorolac Postoperative Pain Percutaneous Nephrolithotomy</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Patients undergo percutaneous nephrolithotomy kidney stone disease History nonsteroidal antiinflammatory drug allergy Asthma History longterm opioid use Intraoperative blood loss great 300 mL Postoperative hemodynamic instability Active peptic ulcer disease Advanced renal impairment ( Creatinine &gt; 2.0 mg/dL ) Bleeding diathesis Current use probenecid Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Percutaneous</keyword>
	<keyword>Nephrolithotomy</keyword>
	<keyword>Kidney stone</keyword>
</DOC>